Dr. Thomas O'Brien is an infectious disease specialist in Boston, Massachusetts. He received his medical degree from Harvard Medical School and has been in practice for 61 years.
In 1995, Dr. O'Brien became a Co-Founder of the WHO Collaborating Centre for Surveillance of Antimicrobial Resistance. And along with Dr. Stelling have been charged with developing, disseminating and supporting the free WHONET software, currently used to support surveillance activities in over 120 countries in over 2,300 hospital, public health, food, and veterinary laboratories.
Dr. John Stelling is Co-Director of the WHO Collaborating Centre for Surveillance of Antimicrobial Resistance based at the Brigham and Women’s Hospital in Boston. He received his undergraduate degree from Johns Hopkins University and Master’s in Public Health from the Johns Hopkins School of Hygiene and Public Health.
In 1991, Dr. Stelling graduated from Harvard Medical School and the Massachusetts Institute of Technology Division of Health Sciences and Technology and in 1995 completed an internship in family practice at San Francisco General Hospital.
The focus of his work has been to support public health infrastructure for laboratory services, including three years as a Medical Officer with the World Health Organization Antimicrobial Resistance Monitoring Unit, and advancing data management tools for laboratory-based surveillance of infectious diseases and antimicrobial resistance.
Since 1989, He has developed, disseminated and supported the free WHONET software, currently used to support surveillance activities in over 120 countries in over 2,300 hospital, public health, food, and veterinary laboratories.
Adam Clark is the principal WHONET software engineer. He has been working with the project since 2011.
Since then, he has greatly refactored and extended the desktop applications WHONET and BacLink, improved the web version of WHONET, and created the WHONET Automation Tool among other accomplishments.
Adam has also developed a number of supporting softwares that have helped streamline the development-to-distribution pipeline and will continue to have a substantive impact for years to come.